Biogenic Ag-doped ZnO nanostructures induced cytotoxicity in luminal A and triple-negative human breast cancer cells-Reference-Cited by-同舟云学术

Biogenic Ag-doped ZnO nanostructures induced cytotoxicity in luminal A and triple-negative human breast cancer cells

Published:2024-05-29 Issue: Volume: Page:1-15
ISSN:1743-5889
Container-title:Nanomedicine
language:en
Short-container-title:Nanomedicine

Author:

Banthia Poonam¹^ORCID,Vyas Rishi²^ORCID,Jain Ankur³^ORCID,Daga Dhiraj⁴^ORCID,Ichikawa Takayuki⁵^ORCID,Kulshrestha Vaibhav⁶,Sharma Asha⁷,Agarwal RD⁸,Kapoor Neha¹^ORCID,Gambhir Lokesh⁹^ORCID,Gautam Shilpi¹,Sharma Gaurav¹^ORCID

Affiliation:

1. School of Applied Sciences, Suresh Gyan Vihar University, Jaipur, Rajasthan 302017, India

2. Department of Physics, Swami Keshvanand Institute of Technology, Management & Gramothan, Jaipur, Rajasthan 302017, India

3. Centre for Renewable Energy & Storage, Suresh Gyan Vihar University, Jaipur, Rajasthan 302017, India

4. Department of Radiation Oncology, Jawahar Lal Nehru Medical College & Hospital, Ajmer, Rajasthan 305001, India

5. Graduate School of Advanced Science & Engineering, Hiroshima University, Higashi, Hiroshima 739-8527, Japan

6. CSIR-Central Salt & Marine Chemical Research Institute, Bhavnagar, Gujarat 364002, India

7. Dept. of Zoology, Swargiya P.N.K.S. Govt. PG College, Dausa, Rajasthan 303303, India

8. Dept. of Botany, retd. Professor, University of Rajasthan, Jaipur, Rajasthan 302004, India

9. School of Basic & Applied Sciences, Shri Guru Ram Rai University, Dehradun, Uttarakhand 248001, India

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/17435889.2024.2347825

Reference96 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Current and future burden of breast cancer: Global statistics for 2020 and 2040

3. Global challenges and policy solutions in breast cancer control

4. Nanomedicine applications in the treatment of breast cancer: current state of the art

5. Peptides, proteins and nanotechnology: a promising synergy for breast cancer targeting and treatment